Renishaw plc Reports Unaudited Consolidated Earnings Results for the Six Months Ended December 31, 2014; Provides Earnings Guidance for the Second Half of 2015; Declares Interim Dividend, Payable on April 7, 2015
January 29, 2015 at 12:30 pm IST
Share
Renishaw plc reported unaudited consolidated earnings results for the six months ended December 31, 2014. For the period, the company's revenue was £223,816,000 against £163,994,000 a year ago. Operating profit was £56,661,000 against £25,526,000 a year ago. Profit before tax was £56,625,000 against £25,629,000 a year ago. Profit for the period from continuing operations was £46,433,000 against £21,144,000 a year ago. Profit attributable to equity shareholders of the parent company was £46,726,000 or 64.2 pence per basic and diluted share against £21,443,000 or 29.5 pence per basic and diluted share a year ago. Cash flows from operating activities were £45,559,000 against £29,686,000 a year ago. Purchase of property, plant and equipment was £18,814,000 against £19,464,000 a year ago. Purchase of other intangibles was £429,000 against £239,000 a year ago. Adjusted profit before taxation was £56,625,000 against £25,629,000 a year ago. Adjusted earnings per share were 64.2 pence against 29.5 pence a year ago.
For the second half of 2015, the trend in revenue growth is expected to continue into the second half of this financial year. The company currently anticipates full year revenue to be in the range of £480 million to £510 million and profit before tax to be in the range of £130 million to £150 million.
The company announced interim dividend of 12.5 pence, this is increased by 10%, from 11.33 pence per share for the same period a year ago. Record date for 2015 interim dividend is March 6, 2015 and payable on April 7, 2015.
Renishaw plc is a United Kingdom-based supplier of measuring systems and production systems. The principal activities of the Company are the design, manufacture, sale, distribution and service of manufacturing technologies products and services, and analytical instruments and medical devices. The Company operates through two segments: manufacturing technologies, and analytical instruments and medical devices. The manufacturing technologies segment consists of four areas: industrial metrology, additive manufacturing, position measurement and the new industrial automation line. The analytical instruments and medical devices segment consist of spectroscopy and neurological, where it supplies its customers with technologies to improve materials analysis and neurological therapies. Its products include CMM probes, software, and retrofits; equator gauging system; interferometric laser encoders; probing and tool measurement systems for machine tools, and others.
Renishaw plc Reports Unaudited Consolidated Earnings Results for the Six Months Ended December 31, 2014; Provides Earnings Guidance for the Second Half of 2015; Declares Interim Dividend, Payable on April 7, 2015